Tularemia, caused by Francisella tularensis, is a zoonotic disease with various sources, transmission routes, and geographically different clinical signs. Diagnosis is challenging due to nonspecific symptoms, highlighting the importance of laboratory testing for accurate detection, effective outbreak management, and targeted treatment. Recent improvements have enhanced the accuracy of sensitive and specific immunological and molecular methods. Techniques such as enzyme-linked immunosorbent assay, immunochromatography, microagglutination tests, indirect immunofluorescence assays, and PCR continue to be key detection tools. Molecular typing methods such as whole-genome sequencing, single-nucleotide polymorphism analysis, multiple-locus variable-number tandem repeat analysis, pulsed-field gel electrophoresis, and matrix-assisted laser desorption ionization-time of flight enable precise genetic characterization of F. tularensis strains. These methods improve understanding of phylogeny, strain diversity, and transmission routes, while supporting outbreak investigations. This review aims to provide a comprehensive overview of current laboratory methods for diagnosing and typing tularemia as well as their application in clinical and research settings.
BäCKAT, FlygareC, ErikssonA, JohanssonA. Acute myocarditis caused by Francisella tularensis: A case report. SN Compr Clin Med2023;5(1):105; doi: 10.1007/s42399-023-01436-w
2.
BerdalBP, MehlR, HaaheimH, et al.Field detection of Francisella tularensis. Scand J Infect Dis, 2000;32(3):287–291; doi: 10.1080/00365540050165938
3.
BorgschulteHS, JacobD, ZeehJ, et al.Ulceroglandular form of tularemia after squirrel bite: A case report. J Med Case Rep2022;16(1):309; doi: 10.1186/s13256-022-03510-8
4.
BrownS, MckinneyF, KleinG, JonesW. Evaluation of a safranin-O-stained antigen microagglutination test for Francisella tularensis antibodies. J Clin Microbiol1980;11(2):146–148; doi: 10.1128/jcm.11.2.146-148.1980
5.
ChrdleA, TINAVSKáP, DVOŘáČKOVáO, et al.Early diagnosis of tularemia by flow cytometry, Czech Republic, 2003–2015. Emerg Infect Dis2019;25(10):1919–1927; doi: 10.3201/eid2510.181875
6.
ClarridgeJE.III., Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev2004;17(4):840–862; doi: 10.1128/cmr.17.4.840-862.2004
7.
DE VriesMC, Hoeve-BakkerB, VAN DEN BeldMJ, et al.Identification of Francisella tularensis subspecies in a clinical setting using MALDI-TOF MS: An in-house Francisella library and biomarkers. Microorganisms2023;11(4):905; doi: 10.3390/microorganisms11040905
8.
EricssonM, SANDSTRöMG, SJöSTEDTA, TäRNVIKA. Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J Infect Dis1994;170(1):110–114; doi: 10.1093/infdis/170.1.110
9.
FooladfarZ, MoradiF. Francisella and tularemia in western Asia, Iran: A systematic review. New Microbes New Infect2023;52:101092; doi: 10.1016/j.nmni.2023.101092
10.
Glinšek BiškupU, KogojR, KorvaM, et al.Characterization of tularemia cases in Slovenia with multiple-locus variable-number tandem repeat analysis. Vector Borne Zoonotic Dis2021;21(5):351–357; doi: 10.1089/vbz.2020.2711
11.
GrunowR, SplettstoesserW, McdonaldS, et al.Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR. Clin Diagn Lab Immunol2000;7(1):86–90; doi: 10.1128/cdli.7.1.86-90.2000
12.
GyuraneczM, BirdsellDN, SplettstoesserW, et al.Phylogeography of Francisella tularensis subsp. holarctica, Europe. Emerg Infect Dis2012;18(2):290–293; doi: 10.3201/eid1802.111305
13.
HepburnMJ, SimpsonAJ. Tularemia: Current diagnosis and treatment options. Expert Rev Anti Infect Ther2008;6(2):231–240; doi: 10.1586/14787210.6.2.231
14.
JohanssonA, ForsmanM, SJöSTEDTA. The development of tools for diagnosis of tularemia and typing of Francisella tularensis. APMIS2004;112(11–12):898–907; doi: 10.1111/j.1600-0463.2004.apm11211-1212.x
15.
KugelerKJ, MeadPS, JanuszAM, et al.Molecular epidemiology of Francisella tularensis in the United States. Clin Infect Dis2009;48(7):863–870; doi: 10.1086/597261
16.
LóPEZ-RamosI, HERNáNDEZM, RODRíGUEZ-LáZAROD, et al.Quick identification and epidemiological characterization of Francisella tularensis by MALDI-TOF mass spectrometry. J Microbiol Methods2020;177:106055; doi: 10.1016/j.mimet.2020.106055
17.
MakdasiE, Atiya-NasagiY, GurD, et al.Iron-modified blood culture media allow for the rapid diagnosis and isolation of the slow-growing pathogen Francisella tularensis. Microbiol Spectr2022;10(5):e02415; doi: 10.1128/spectrum.02415-22
18.
MaurinM, GyuraneczM. Tularaemia: Clinical aspects in Europe. Lancet Infect Dis2016;16(1):113–124.
19.
MaurinM. Francisella tularensis, tularemia and serological diagnosis. Front Cell Infect Microbiol2020;10:512090; doi: 10.3389/fcimb.2020.512090
20.
MorseS, HenkelR. Francisella tularensis: Understanding reported occupational exposures and laboratory methods used for the identification of Francisella tularensis. Appl Biosaf2018;23(1):11–18; doi: 10.1177/1535676017746695
21.
MullerSE, SchneitlerS, ZangeS, et al.Clinical characteristics of and diagnostic approaches to human Francisella tularensis infection: A retrospective, monocentric case study from Germany. Ticks Tick Borne Dis2025;16(4):102492; doi: 10.1016/j.ttbdis.2025.102492
22.
NagaratnamN, Martin-GarciaJM, YangJ-H, et al.Structural and biophysical properties of FopA, a major outer membrane protein of Francisella tularensis. PLoS One2022;17(8):e0267370; doi: 10.1371/journal.pone.0267370
23.
OharaS, SatoT, HommaM. Serological studies on Francisella tularensis, Francisella novicida, Yersinia philomiragia, and Brucella abortus. Int J Syst Evol Microbiol1974;24(2):191–196; doi: 10.1099/00207713-24-2-191
24.
PalM, ShuramoMY, GutamaKP. Tularaemia: A Re-emerging infectious zoonotic disease of public health significance. IJCEMR2021;6(1):48–51.
25.
PetersenJM, SchrieferME, CarterLG, et al.Laboratory analysis of tularemia in wild-trapped, commercially traded prairie dogs, Texas, 2002. Emerg Infect Dis2004;10(3):419–425; doi: 10.3201/eid1003.030504
26.
PohankaM. Immunosensors and immunoassays to detect Francisella tularensis and diagnose tularemia. Biosensors (Basel)2026;16(3):158; doi: 10.3390/bios16030158
27.
PonderandL, GuimardT, LazaroE, et al.Case studies and literature review of Francisella tularensis–Related prosthetic joint infection. Emerg Infect Dis2023;29(6):1118–1126; doi: 10.3201/eid2906.221395
28.
Porsch-OzcürümezM, KischelN, PriebeH, et al.Comparison of enzyme-linked immunosorbent assay, western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for serological diagnosis of tularemia. Clin Diagn Lab Immunol2004;11(6):1008–1015; doi: 10.1128/CDLI.11.6.1008-1015.2004
29.
SCHöBIN, AgyemanPK, DuppenthalerA, et al.Pediatric tularemia—A case series from a single center in Switzerland. Open Forum Infect Dis2022;9(7):ofac292; doi: 10.1093/ofid/ofac292
30.
SewellDL. Laboratory safety practices associated with potential agents of biocrime or bioterrorism. J Clin Microbiol2003;41(7):2801–2809; doi: 10.1128/jcm.41.7.2801-2809.2003
31.
SJöSTEDTA. Tularemia: History, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci2007;1105:1–29; doi: 10.1196/annals.1409.009
32.
SplettstoesserW, TomasoH, Al DahoukS, et al.Diagnostic procedures in tularaemia with special focus on molecular and immunological techniques. J Vet Med B Infect Dis Vet Public Health2005;52(6):249–261; doi: 10.1111/j.1439-0450.2005.00863.x
33.
SYRJäLäH, KoskelaP, RipattiT, et al.Agglutination and ELISA methods in the diagnosis of tularemia in different clinical forms and severities of the disease. J Infect Dis1986;153(1):142–145.
TäRNVIKA, ChuMC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci2007;1105:378–404; doi: 10.1196/annals.1409.017
36.
VoglerAJ, BirdsellD, PriceLB, et al.Phylogeography of Francisella tularensis: Global expansion of a highly fit clone. J Bacteriol2009;191(8):2474–2484; doi: 10.1128/jb.01786-08
37.
WahabT, BirdsellDN, HjertqvistM, et al.Insights to genetic characterization tools for epidemiological tracking of Francisella tularensis in Sweden. PLoS One2014;9(11):e112167; doi: 10.1371/journal.pone.0112167
38.
WawszczakM, BanaszczakB, RastawickiW. Tularaemia - A diagnostic challenge. Ann Agric Environ Med2022;29(1):12–21; doi: 10.26444/aaem/139242
39.
World Health Organization. WHO guidelines on tularaemia: epidemic and pandemic alert and response. World Health Organization; 2007.
40.
YanesH, HennebiqueA, PellouxI, et al.Evaluation of in-house and commercial serological tests for diagnosis of human tularemia. J Clin Microbiol2018;56(1):e01440–e01417; doi: 10.1128/jcm.01440-17
